Literature DB >> 15125841

Ssu72 Is an RNA polymerase II CTD phosphatase.

Shankarling Krishnamurthy1, Xiaoyuan He, Mariela Reyes-Reyes, Claire Moore, Michael Hampsey.   

Abstract

Phosphorylation of serine-2 (S2) and serine-5 (S5) of the C-terminal domain (CTD) of RNA polymerase II (RNAP II) is a dynamic process that regulates the transcription cycle and coordinates recruitment of RNA processing factors. The Fcp1 CTD phosphatase catalyzes dephosphorylation of S2-P. Here, we report that Ssu72, a component of the yeast cleavage/polyadenylation factor (CPF) complex, is a CTD phosphatase with specificity for S5-P. Ssu72 catalyzes CTD S5-P dephosphorylation in association with the Pta1 component of the CPF complex, although its essential role in 3' end processing is independent of catalytic activity. Depletion of Ssu72 impairs transcription in vitro, and this defect can be rescued by recombinant, catalytically active Ssu72. We propose that Ssu72 has a dual role in transcription, one as a CTD S5-P phosphatase that regenerates the initiation-competent, hypophosphorylated form of RNAP II and the other as a factor necessary for cleavage of pre-mRNA and efficient transcription termination.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15125841     DOI: 10.1016/s1097-2765(04)00235-7

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  115 in total

Review 1.  The RNA polymerase II CTD "orphan" residues: Emerging insights into the functions of Tyr-1, Thr-4, and Ser-7.

Authors:  Nathan M Yurko; James L Manley
Journal:  Transcription       Date:  2017-10-04

2.  Ssu72 phosphatase-dependent erasure of phospho-Ser7 marks on the RNA polymerase II C-terminal domain is essential for viability and transcription termination.

Authors:  David W Zhang; Amber L Mosley; Sreenivasa R Ramisetty; Juan B Rodríguez-Molina; Michael P Washburn; Aseem Z Ansari
Journal:  J Biol Chem       Date:  2012-01-10       Impact factor: 5.157

3.  Control of the RNA polymerase II phosphorylation state in promoter regions by CTD interaction domain-containing proteins RPRD1A and RPRD1B.

Authors:  Zuyao Ni; Jonathan B Olsen; Xinghua Guo; Guoqing Zhong; Eric Dongliang Ruan; Edyta Marcon; Peter Young; Hongbo Guo; Joyce Li; Jason Moffat; Andrew Emili; Jack F Greenblatt
Journal:  Transcription       Date:  2011 Sep-Oct

4.  Recent molecular insights into canonical pre-mRNA 3'-end processing.

Authors:  Yadong Sun; Keith Hamilton; Liang Tong
Journal:  Transcription       Date:  2020-06-11

Review 5.  Control of eukaryotic gene expression: gene loops and transcriptional memory.

Authors:  Michael Hampsey; Badri Nath Singh; Athar Ansari; Jean-Philippe Lainé; Shankarling Krishnamurthy
Journal:  Adv Enzyme Regul       Date:  2010-10-29

6.  A role for the CPF 3'-end processing machinery in RNAP II-dependent gene looping.

Authors:  Athar Ansari; Michael Hampsey
Journal:  Genes Dev       Date:  2005-11-30       Impact factor: 11.361

Review 7.  Sub1/PC4, a multifaceted factor: from transcription to genome stability.

Authors:  Miguel Garavís; Olga Calvo
Journal:  Curr Genet       Date:  2017-05-31       Impact factor: 3.886

8.  CREPT serves as a biomarker of poor survival in pancreatic ductal adenocarcinoma.

Authors:  Gang Yang; Yicheng Wang; Jianchun Xiao; Fangyu Zhao; Jiangdong Qiu; Yueze Liu; Guangyu Chen; Zhe Cao; Lei You; Lianfang Zheng; Taiping Zhang; Yupei Zhao
Journal:  Cell Oncol (Dordr)       Date:  2020-10-30       Impact factor: 6.730

9.  Arabidopsis C-terminal domain phosphatase-like 1 and 2 are essential Ser-5-specific C-terminal domain phosphatases.

Authors:  Hisashi Koiwa; Stéphane Hausmann; Woo Young Bang; Akihiro Ueda; Naoko Kondo; Akihiro Hiraguri; Toshiyuki Fukuhara; Jeong Dong Bahk; Dae-Jin Yun; Ray A Bressan; Paul M Hasegawa; Stewart Shuman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-23       Impact factor: 11.205

Review 10.  How eukaryotic genes are transcribed.

Authors:  Bryan J Venters; B Franklin Pugh
Journal:  Crit Rev Biochem Mol Biol       Date:  2009-06       Impact factor: 8.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.